Deciphera Pharmaceuticals Inc (DCPH) is down -4.76% in a Week, Should You Hold?

Deciphera Pharmaceuticals Inc (DCPH) is near the top in its industry group according to InvestorsObserver. DCPH gets an overall rating of 57. That means it scores higher than 57 percent of stocks. Deciphera Pharmaceuticals Inc gets a 81 rank in the Drug Manufacturers - Specialty & Generic industry. Drug Manufacturers - Specialty & Generic is number 105 out of 148 industries.

DCPH has an Overall Score of 57. Find out what this means to you and get the rest of the rankings on DCPH!

See Full DCPH Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Deciphera Pharmaceuticals Inc Stock Today?

Deciphera Pharmaceuticals Inc (DCPH) stock has gained 1.67% while the S&P 500 is lower by -0.07% as of 9:37 AM on Wednesday, Mar 20. DCPH is higher by $0.25 from the previous closing price of $14.97 on volume of 0 shares. Over the past year the S&P 500 is up 29.28% while DCPH is lower by -1.23%. DCPH lost -$2.29 per share the over the last 12 months. Click Here to get the full Stock Report for Deciphera Pharmaceuticals Inc stock.